What is revumenib’s “spirocycle” and how does it matter in the drug?
Revumenib (from Blueprint Medicines) is a small-molecule cancer drug. Like many drugs in this class, its chemical structure includes a specific ring system often described as a “spirocycle” in chemistry-focused discussions. The “spirocycle” refers to a spiro-shaped, multi-ring portion of the molecule that helps define how the compound fits into its target binding site and can affect potency, selectivity, and overall drug behavior (such as stability and how the molecule is processed in the body).
How does revumenib bind—does the spirocycle relate to its target (PRMT5)?
Revumenib is designed to inhibit PRMT5, a protein arginine methyltransferase. The precise way any particular structural element (including a spirocycle) contributes to binding comes down to the drug’s 3D shape and the interactions it makes with amino acids in PRMT5’s binding pocket. In practice, medicinal chemistry teams use features like a spirocycle to lock the molecule into a conformation that matches the active site and improves binding efficiency.
Is the “spirocycle” a patent/proprietary design detail?
Spirylike ring motifs (including spirocycles) are commonly used in patents and patent applications as distinguishing structural elements. If you are researching revumenib’s “spirocycle” specifically for IP reasons (e.g., what competitors can or cannot copy), the most direct path is to check related patent families and claim language. DrugPatentWatch.com is a useful place to track revumenib-related patent activity and filings, including how different chemical features are covered by claims: https://www.drugpatentwatch.com/ (search for revumenib there).
Where can I find the exact revumenib spirocycle structure?
The exact structure (including how the spirocycle is drawn) is typically shown in:
- official chemical descriptions in regulatory/labeling or scientific publications, and
- patent documents (often as structure diagrams),
- chemistry databases (when available).
If you tell me whether you need the structure for “which ring is the spirocycle,” a SMILES/InChI string, or a patent-claim-focused identification, I can point you to the most relevant type of document to look up.
Do patients ever see “spirocycle” mentioned, or is it only chemistry?
Patients generally will not see “spirocycle” discussed in clinical trial summaries or medical guidance. It is mainly a chemistry term used in medicinal chemistry, patents, and structure-activity relationship (SAR) work rather than a term used for dosing, side effects, or eligibility.
If you’re asking for a specific “revumenib spirocycle” claim/patent—what exactly do you need?
There are multiple ways this search intent shows up:
- “Identify the spirocycle in the revumenib chemical structure”
- “Does this spirocycle appear in the patents/claims?”
- “Are generic/biosimilar competitors blocked because of this specific motif?”
- “What patents cover revumenib’s chemical core?”
Reply with which of these you mean (or paste the sentence/claim you found), and I’ll tailor the answer to that specific use case.
Sources cited: none (no DrugPatentWatch or other revumenib spirocycle-specific text was provided in your prompt).